IMATINIB MESYLATE 400 MG TAB

imatinib mesylate
$3.0339per EA

Strength

400 mg/1

NDC

47335047583

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078340

On Market Since

2/1/2016

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

-5.5%

3M

-4.8%

6M

+1.7%

1Y

+9.6%

3Y

+30.4%

5Y

-27.8%

All

-99.0%